Sign In
Buy CRL
$232.51
-2.11 (-0.90%)
At Close: Jul 31, 2026
Charles River Laboratories Announces First-Quarter 2026 Results
07:00am, Thursday, 07'th May 2026
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories Announces First-Quarter 2026 Financial Results.
Charles River (CRL) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
10:15am, Wednesday, 06'th May 2026
Evaluate the expected performance of Charles River (CRL) for the quarter ended March 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metri
Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
11:06am, Thursday, 30'th Apr 2026
Charles River (CRL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Charles River Launches Rat In Vitro Fertility Services Demonstrating Embryology Capabilities
08:00am, Thursday, 30'th Apr 2026
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories today announced an enhanced In Vitro Fertility (IVF) service bundle designed to accelerate rat-model programs across thera
Here's Why Charles River Laboratories (CRL) is a Strong Value Stock
10:45am, Tuesday, 28'th Apr 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Charles River Associates (CRA) to Host First-Quarter Fiscal 2026 Financial Results Conference Call on May 7
08:30am, Thursday, 23'rd Apr 2026
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that the company will webcast
Charles River Highlights Effectiveness of VCGs in Toxicology
08:00am, Tuesday, 21'st Apr 2026
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories International, Inc. (NYSE: CRL) has shared the results of a retrospective analysis in Regulatory Toxicology and Pharmacolo
Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report?
01:11pm, Tuesday, 14'th Apr 2026
Charles River (CRL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Massachusetts Financial Services Co. MA Takes Position in Charles River Laboratories International, Inc. $CRL
06:10am, Monday, 13'th Apr 2026
Massachusetts Financial Services Co. MA acquired a new stake in Charles River Laboratories International, Inc. (NYSE: CRL) during the undefined quarter, according to its most recent disclosure with th
Charles River Advances Cardiovascular Health Awareness Through Support of the American Heart Association
04:30pm, Thursday, 09'th Apr 2026
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories International, Inc. (NYSE: CRL) today announced a collaboration with the American Heart Association, the world's leading n
Charles River Laboratories International, Inc. (NYSE:CRL) Receives Average Recommendation of “Moderate Buy” from Brokerages
02:39am, Wednesday, 08'th Apr 2026
Shares of Charles River Laboratories International, Inc. (NYSE: CRL - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the fifteen ratings firms that are covering t
NYSE Content Update: Join Us and 6,500+ Attendees at Marquee AI Event HumanX
08:55am, Monday, 06'th Apr 2026
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, April 6, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the N
Allspring Global Investments Holdings LLC Cuts Stock Holdings in Charles River Laboratories International, Inc. $CRL
03:18am, Tuesday, 31'st Mar 2026
Allspring Global Investments Holdings LLC trimmed its stake in Charles River Laboratories International, Inc. (NYSE: CRL) by 8.4% during the undefined quarter, according to the company in its most rec
Contravisory Investment Management Inc. Takes $1.22 Million Position in Charles River Laboratories International, Inc. $CRL
01:42pm, Tuesday, 24'th Mar 2026
Contravisory Investment Management Inc. bought a new position in Charles River Laboratories International, Inc. (NYSE: CRL) during the undefined quarter, according to the company in its most recent Fo
Why Is Charles River (CRL) Down 6.8% Since Last Earnings Report?
12:31pm, Friday, 20'th Mar 2026
Charles River (CRL) reported earnings 30 days ago. What's next for the stock?
